Highvista Strategies is an investment fund managing more than $244 billion ran by Ron Landen. There are currently 125 companies in Mr. Landen’s portfolio. The largest investments include Spyre Therapeutics Inc and Microsoft, together worth $17.9 billion.

Limited to 30 biggest holdings

$244 billion Assets Under Management (AUM)

As of 7th February 2024, Highvista Strategies’s top holding is 577,616 shares of Spyre Therapeutics Inc currently worth over $12.4 billion and making up 5.1% of the portfolio value.In addition, the fund holds 14,458 shares of Microsoft worth $5.44 billion, whose value grew 28.2% in the past six months. The third-largest holding is Immunovant Inc worth $5.11 billion and the next is Axsome Therapeutics Inc worth $4.96 billion, with 62,263 shares owned.

Currently, Highvista Strategies's portfolio is worth at least $244 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Highvista Strategies

The Highvista Strategies office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Ron Landen serves as the Chief Compliance Officer at Highvista Strategies.